We are live on ! Find out more
RPCA

Running Point Capital Advisors Portfolio holdings

AUM $367M
1-Year Est. Return 12.19%
This Fund
S&P 500
This Quarter Est. Return
-13.8%
1 Year Est. Return
+12.19%
3 Year Est. Return
+52.1%
5 Year Est. Return
+37.6%
10 Year Est. Return
AUM
$156M
AUM Growth
-$15.1M
Cap. Flow
+$10.5M
Cap. Flow %
6.72%
Top 10 Hldgs %
54.35%
Holding
239
New
22
Increased
36
Reduced
42
Closed
10

Sector Composition

Rank Sector Weight
1 Technology 3.11%
2 Financials 2.47%
3 Communication Services 2.32%
4 Healthcare 1.05%
5 Consumer Staples 0.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VOE icon
176
Vanguard Morningstar Mid-Cap Value ETF
VOE
$23.9B
$28K 0.02%
219
IAGG icon
177
iShares Core International Aggregate Bond Fund
IAGG
$10.9B
$27K 0.02%
545
VCLT icon
178
Vanguard Long-Term Corporate Bond ETF
VCLT
$8.81B
$26K 0.02%
326
+81
+33% +$6.83K
TRHC
179
DELISTED
Tabula Rasa HealthCare, Inc. Common Stock
TRHC
$26K 0.02%
10,000
-23
-0.2% -$86
AMRN
180
Amarin Corp
AMRN
$297M
$24K 0.02%
805
BWZ icon
181
State Street SPDR Bloomberg Short Term International Treasury Bond ETF
BWZ
$264M
$24K 0.02%
903
GRTS
182
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$24K 0.02%
10,000
ASMB icon
183
Assembly Biosciences
ASMB
$498M
$21K 0.01%
833
IJK icon
184
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.6B
$21K 0.01%
+327
New +$23K
SRNE
185
DELISTED
Sorrento Therapeutics, Inc.
SRNE
$20K 0.01%
10,000
ADVM
186
DELISTED
Adverum Biotechnologies
ADVM
$18K 0.01%
1,500
DHC
187
Diversified Healthcare Trust
DHC
$2.15B
$18K 0.01%
10,000
IEF icon
188
iShares 7-10 Year Treasury Bond ETF
IEF
$47.2B
$18K 0.01%
176
RPG icon
189
Invesco S&P 500 Pure Growth ETF
RPG
$1.9B
$18K 0.01%
600
CLVS
190
DELISTED
Clovis Oncology, Inc.
CLVS
$18K 0.01%
10,000
ADAP
191
DELISTED
Adaptimmune Therapeutics
ADAP
$17K 0.01%
10,000
INO icon
192
Inovio Pharmaceuticals
INO
$85.6M
$17K 0.01%
833
IRON icon
193
Disc Medicine
IRON
$2.81B
$17K 0.01%
333
IWR icon
194
iShares Russell Mid-Cap ETF
IWR
$55.9B
$17K 0.01%
268
SCTL
195
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$16K 0.01%
20,000
XERS icon
196
Xeris Biopharma Holdings
XERS
$1.45B
$15K 0.01%
10,000
ICVT icon
197
iShares Convertible Bond ETF
ICVT
$6.97B
$14K 0.01%
204
VTV icon
198
Vanguard Morningstar Value ETF
VTV
$188B
$13K 0.01%
100
REZ icon
199
iShares Residential and Multisector Real Estate ETF
REZ
$906M
$12K 0.01%
146
VB icon
200
Vanguard Morningstar Small-Cap ETF
VB
$78.9B
$12K 0.01%
70

Similar funds

Running Point Capital Advisors's Q2 2022 Portfolio in Review

As of Q2 2022, Running Point Capital Advisors held 239 positions worth $156M, down 8.8% from $171M the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Running Point Capital Advisors deployed $10.5M of net new capital in Q2 2022, opening 22 new positions and adding to 36 existing holdings. Its largest new stake was Dimensional US Marketwide Value ETF: 45,252 shares worth $1.43M.

By sector, the portfolio is most concentrated in Technology at 3.1% of assets, down from 4% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was State Street SPDR Portfolio Emerging Markets ETF, an estimated $1.62M trimmed.

  • Running Point Capital Advisors's largest Q2 2022 buy was Dimensional US Marketwide Value ETF: 45,252 shares worth $1.43M.
  • Running Point Capital Advisors added most to Invesco QQQ Trust in Q2 2022, an estimated $2.05M increase.
  • Running Point Capital Advisors's biggest Q2 2022 reduction was State Street SPDR Portfolio Emerging Markets ETF, cutting an estimated $1.62M.
  • Running Point Capital Advisors fully exited NVIDIA in Q2 2022, selling an estimated $281K.
  • Running Point Capital Advisors's ten largest holdings make up 54% of its $156M portfolio in Q2 2022.
  • Running Point Capital Advisors opened 22 new positions and closed 10 in Q2 2022.
  • Running Point Capital Advisors's portfolio value fell 8.8% quarter-over-quarter to $156M.

Based on Running Point Capital Advisors's 13F filing for Q2 2022, filed 2 Aug 2022.